Mailed fecal immunochemical tests plus educational materials to improve colon cancer screening rates in Iowa Research Network (IRENE) practices

Journal of the American Board of Family Medicine

Volumn 25, Issue 1, 2012, Pages 73-82

  Levy, Barcey T ^a,b   Daly, Jeanette M ^a   Xu, Yinghui ^a   Ely, John W ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Cancer screening; Colorectal cancer; Health education; Practice based research; Randomized clinical trials; Rural health

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CANCER DIAGNOSIS; CANCER SCREENING; COLON CANCER; EDUCATIONAL MODEL; EDUCATIONAL STATUS; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; FOLLOW UP; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; IMMUNOCHEMISTRY; INCOME; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; SCORING SYSTEM; TELEPHONE; UNITED STATES;

COLONIC NEOPLASMS; DATA COLLECTION; FECES; FEMALE; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; IMMUNOCHEMISTRY; IOWA; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; POSTAL SERVICE; TEACHING MATERIALS;

EID: 84862908589     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2012.01.110055     Document Type: Article

References (39)

1. Subramanian S, Bobashev G, Morris RJ. Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance. Cancer Epidemiol Biomarkers Prev 2009;18(7):1971-8.
2. Vogelaar I, van Ballegooijen M, Schrag D, et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer 2006;107(7): 1624-33. (Pubitemid 44546924)
3. National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention. CDC Vital Signs. Colorectal cancer: 1 in 3 adults are not being screened. Available at www. cdc.gov/VitalSigns/pdf/2011-07-vitalsigns.pdf. Updated 2011. Accessed July 13, 2011.
4. National Cancer Institute. Colorectal cancer screening (PDQ). Available at http://www.cancer. gov/cancertopics/pdq/screening/colorectal/Health Professional. Accessed July 13, 2011.
5. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627-37.
6. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134(5):1570-95. (Pubitemid 351615355)
7. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. Cancer J Clin 2010;60(2):99-119.
8. Yeazel M, Church TR, Jones RM, et al. Colorectal cancer screening adherence in a general population. Cancer Epidemiol Biomarkers Prev 2004;13(4): 654-7. (Pubitemid 38737904)
9. Levy BT, Dawson J, Hartz AJ, James PA. Colorectal cancer testing among patients cared for by Iowa family physicians. Am J Prev Med 2006;31(3):193-201. (Pubitemid 44176305)
10. Crawford ND, Jones CP, Richardson LC. Understanding racial and ethnic disparities in colorectal cancer screening: Behavioral Risk Factor Surveillance System, 2002 and 2004. Ethn Dis 2010;20(4): 359-65.
11. Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002;136(9):641-51. (Pubitemid 34462676)
12. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 2004;39(4 Pt 1):1005-26. (Pubitemid 38924690)
13. Hollon MF. Direct-to-consumer advertising: a haphazard approach to health promotion. JAMA 2005; 293(16):2030-3. (Pubitemid 40570899)
14. Kravitz RL, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 2005;293(16):1995-2002. (Pubitemid 40570893)
15. Wolf RL, Basch CE, Brouse CH, Shmukler C, Shea S. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health 2006;96(5):809-11.
16. Almog R, Ezra G, Lavi I, Rennert G, Hagoel L. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prev 2008;17(5):430-7.
17. DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med 2008;23(2):169-74.
18. Collaborative Institutional Training Initiative [Homepage]. Available at https://www.citiprogram. org/. Accessed November 5, 2010.
19. Dillman DA. Mail and Internet surveys: the tailored design method. 2nd ed. Hoboken, NJ: John Wiley & Sons; 2007.
20. Daly JM, Xu Y, Ely JW, Levy BT. A randomized colorectal cancer screening intervention trial in the Iowa Research Network (IRENE): study recruitment methods and baseline results. J Am Board Fam Med 2011;25:63-72.
21. Levy BT, Nordin T, Sinift S, Rosenbaum M, James PA. Why hasn't this patient been screened for colon cancer? An Iowa Research Network study. J Am Board Fam Med 2007;20(5):458-68. (Pubitemid 350096946)
22. Vernon SW, Myers RE, Tilley BC. Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev 1997;6(10):825-32. (Pubitemid 27435482)
23. Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 2008;44(15):2254-8.
24. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135(1):82-90. (Pubitemid 351899018)
25. Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006;107(9):2152-9. (Pubitemid 44665648)
26. Quintero E, Gimeno-Garcia AZ, Parra-Blanco A, et al. One-time screening with an immunochromatographic occult blood test predicts the detection of advanced adenoma and colorectal cancer in the average-risk population. Can J Gastroenterol 2005; 19(Suppl B):21B.
27. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149(9): 638-58.
28. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149(9):659-69.
29. Myers RE, Sifri R, Hyslop T, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer 2007;110(9):2083-91. (Pubitemid 350036870)
30. Mosen DM, Feldstein AC, Perrin N, et al. Automated telephone calls improved completion of fecal occult blood testing. Med Care 2010;48(7):604-10.
31. Zhu J, Davis J, Taira DA, Yamashita M. Screening rates and characteristics of health plan members who respond to screening reminders. Prev Chronic Dis 2006;3(2):A56.
32. Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ. Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med 2009;169(4):364-71.
33. Rawl SM, Champion VL, Scott LL, et al. A randomized trial of two print interventions to increase colon cancer screening among first-degree relatives. Patient Educ Couns 2008;71(2):215-27. (Pubitemid 351434534)
34. Daly JM, Levy BT, Merchant ML, Wilbur J. Mailed fecal-immunochemical test for colon cancer screening. J Community Health 2010;35(3):235-9.
35. Ling BS, Schoen RE, Trauth JM, et al. Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening. Arch Intern Med 2009;169(1):47-55.
36. Wei EK, Ryan CT, Dietrich AJ, Colditz GA. Improving colorectal cancer screening by targeting office systems in primary care practices: disseminating research results into clinical practice. Arch Intern Med 2005;165(6):661-6. (Pubitemid 40393149)
37. Ornstein S, Nemeth LS, Jenkins RG, Nietert PJ. Colorectal cancer screening in primary care: translating research into practice. Med Care 2010;48(10): 900-6.
38. Nease DE Jr, Ruffin MT, Klinkman MS, Jimbo M, Braun TM, Underwood JM. Impact of a generalizable reminder system on colorectal cancer screening in diverse primary care practices: a report from the prompting and reminding at encounters for prevention project. Med Care 2008;46(9 Suppl 1):S68-73.
39. Klabunde C, Lanier D, Breslau ES, et al. Improving colorectal cancer screening in primary care practice: innovative strategies and future directions. J Gen Intern Med 2007;22:1195-205. (Pubitemid 47038049)